Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males
Clinical trial NCT00540553 · COMPLETED
Trial details
- NCT number
- NCT00540553
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2008-04-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.